Afghanistan vs Georgia: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Georgia
100.0%
in 2024
Afghanistan rank
1st
Georgia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Georgia
How they compare
Afghanistan currently reports 100.0% against 100.0% in Georgia, a difference of 0.0%.
The two have swapped places 3 times across 14 shared years of data; in 2009 it was Afghanistan ahead.
Afghanistan ranks 1st and Georgia ranks 1st of 144 countries.
Across the 3 decades both report, Afghanistan averaged higher in 2 and Georgia in 1.
Head to head by decade
| Decade | Afghanistan | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 55.0% | 45.0% | Afghanistan |
| 2010s | 78.8% | 88.9% | 10.1% | Georgia |
| 2020s | 100.0% | 96.6% | 3.4% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Georgia?
- Afghanistan, at 100.0% against 100.0% in Georgia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Georgia?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Georgia?
- 14 years are reported by both, from 2009 to 2024.
- How do Afghanistan and Georgia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Georgia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.